YBX1 and acute myeloid leukemia: Adding an important point to these studies, we evidenced through in vitro trilineage differentiation assay that AML‐sEVs reduce the osteoblastic differentiation of BM‐MSCs, and the observed effect is likely due to the RNA‐binding protein associated with AML‐sEVs, YBX1.